Insecticide-Resistance Genes Affect Vector Competence for West Nile Virus
In a context of overuse of insecticides, which leads to the selection of resistant mosquitoes, it is already known that this resistance to insecticides affects interactions between mosquitoes and the pathogens they transmit. Researchers from the Institut Pasteur (Paris) and its partners prove that mechanisms of insecticide resistance, observed in Culex quinquefasciatus vector, impact the transmission of West Nile virus.
Over the last decades, arthropod-borne viruses (arboviruses) that affect human health such as dengue, chikungunya, Zika or West Nile viruses have taken the center stage owing to epidemic outbreaks or even pandemics affecting the world. In the absence of vaccines and therapeutic treatments, the control of arboviruses relies mainly on the control of mosquito populations.
The use of insecticides has long been the unique method to reduce mosquito densities and thus interrupt the transmission of arboviruses. However, the overuse of insecticides leads to the selection of mosquitoes with insecticide resistance genes. Insecticide resistance has been reported to affect interactions between mosquitoes and the pathogens they transmit.
"We provide the first evidence of the impact of two main mechanisms of insecticide resistance on arbovirus transmission," explains Anna-Bella Failloux, head of the Arboviruses and Insect Vectors laboratory at the Institut Pasteur. "Using experimental infections, we compared the vector competence of insecticide-resistant and -susceptible Culex quinquefasciatus mosquitoes (target modification and overproduction of detoxification enzymes) to two arboviruses, Rift Valley fever virus (RVFV) and West Nile Virus (WNV)."
For RVFV, vector competence remains unchanged whether the mosquito is resistant or susceptible. However, resistant mosquitoes transmit better WNV than susceptible mosquitoes.
"Our results underscore the importance of understanding the effects of insecticide resistance on vector competence and require reconsidering vector control strategies by limiting the production of insecticide-resistant mosquitoes.," she adds.
Source: Institut Pasteur
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
